- Home
- GNFT vs NCZ Comparison
GNFT vs NCZ Comparison
Compare GNFT & NCZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- NCZ
- Stock Information
- Founded
- GNFT 1999
- NCZ 2003
- Country
- GNFT France
- NCZ United States
- Employees
- GNFT N/A
- NCZ N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- NCZ Finance Companies
- Sector
- GNFT Health Care
- NCZ Finance
- Exchange
- GNFT Nasdaq
- NCZ Nasdaq
- Market Cap
- GNFT 296.4M
- NCZ 240.5M
- IPO Year
- GNFT 2019
- NCZ N/A
- Fundamental
- Price
- GNFT $4.23
- NCZ $3.26
- Analyst Decision
- GNFT Strong Buy
- NCZ
- Analyst Count
- GNFT 1
- NCZ 0
- Target Price
- GNFT $13.00
- NCZ N/A
- AVG Volume (30 Days)
- GNFT 7.5K
- NCZ 533.0K
- Earning Date
- GNFT 09-19-2024
- NCZ 01-01-0001
- Dividend Yield
- GNFT N/A
- NCZ 12.16%
- EPS Growth
- GNFT N/A
- NCZ N/A
- EPS
- GNFT 0.47
- NCZ N/A
- Revenue
- GNFT $86,225,222.00
- NCZ N/A
- Revenue This Year
- GNFT $155.44
- NCZ N/A
- Revenue Next Year
- GNFT N/A
- NCZ N/A
- P/E Ratio
- GNFT $8.98
- NCZ N/A
- Revenue Growth
- GNFT 175.45
- NCZ N/A
- 52 Week Low
- GNFT $3.08
- NCZ $2.50
- 52 Week High
- GNFT $6.42
- NCZ $3.15
- Technical
- Relative Strength Index (RSI)
- GNFT 27.92
- NCZ 59.57
- Support Level
- GNFT $4.17
- NCZ $3.05
- Resistance Level
- GNFT $4.45
- NCZ $3.32
- Average True Range (ATR)
- GNFT 0.14
- NCZ 0.05
- MACD
- GNFT -0.10
- NCZ 0.01
- Stochastic Oscillator
- GNFT 3.66
- NCZ 75.93
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About NCZ Virtus Convertible & Income Fund II of Beneficial Interest
Virtus Convertible & Income Fund II is a diversified, closed-end management investment company. Its investment objective is to provide total return through a combination of capital appreciation and high current income. Its portfolio of investments includes different sector investments such as in healthcare services, media, oil, gas and consumable fuels and others.